Unknown

Dataset Information

0

Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.


ABSTRACT: Multidrug resistance (MDR) in cancer cells is a challenging phenomenon often associated with P-glycoprotein (Pgp) surface expression. Finding new ways to bypass Pgp-mediated MDR still remains a daunting challenge towards the successful treatment of malignant neoplasms such as colorectal cancer.We applied the Cell Surface Capture technology to chemosensitive and chemoresistant human colon cancer to explore the cell surface proteome of Pgp-expressing cells in a discovery-driven fashion. Comparative quantitative analysis of identified cell surface glycoproteins revealed carbonic anhydrase type XII (CAXII) to be up-regulated on the surface of chemoresistant cells, similarly to Pgp. In cellular models showing an acquired MDR phenotype due to the selective pressure of chemotherapy, the progressive increase of the transcription factor hypoxia-inducible factor-1 alpha was paralleled by the simultaneous up-regulation of Pgp and CAXII. CAXII and Pgp physically interacted at the cell surface. CAXII silencing or pharmacological inhibition with acetazolamide decreased the ATPase activity of Pgp by altering the optimal pH at which Pgp operated and promoted chemosensitization to Pgp substrates in MDR cells.We propose CAXII as a new secondary marker of the MDR phenotype that influences Pgp activity directly and can be used as a pharmacological target for MDR research and potential treatment.

SUBMITTER: Kopecka J 

PROVIDER: S-EPMC4466649 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.

Kopecka Joanna J   Campia Ivana I   Jacobs Andrea A   Frei Andreas P AP   Ghigo Dario D   Wollscheid Bernd B   Riganti Chiara C  

Oncotarget 20150301 9


Multidrug resistance (MDR) in cancer cells is a challenging phenomenon often associated with P-glycoprotein (Pgp) surface expression. Finding new ways to bypass Pgp-mediated MDR still remains a daunting challenge towards the successful treatment of malignant neoplasms such as colorectal cancer.We applied the Cell Surface Capture technology to chemosensitive and chemoresistant human colon cancer to explore the cell surface proteome of Pgp-expressing cells in a discovery-driven fashion. Comparativ  ...[more]

Similar Datasets

| S-EPMC9333239 | biostudies-literature
| S-EPMC5349880 | biostudies-literature
| S-EPMC6242694 | biostudies-literature
| S-EPMC6162069 | biostudies-literature
| S-EPMC6142056 | biostudies-literature
| S-EPMC7763246 | biostudies-literature
| S-EPMC10707797 | biostudies-literature
| S-EPMC7236253 | biostudies-literature
| S-EPMC2978943 | biostudies-literature
| S-EPMC8095314 | biostudies-literature